Mitogen-Activated Protein Kinase Kinase 2 Inhibitors

DBCAT005517Pharmacologic class

A DrugBank category of 1 drug. 1 of them is approved.

What you can answer from here — as of July 28, 2021

1DrugEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

16Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Mitogen-Activated Protein Kinase Kinase 2 Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.